Wall Street analysts change outlook on top stocks, including LIME, CIFR, BSP, DMRA, and ITG. Check analyst ratings page for full view.
Jefferies initiated coverage on Damora Therapeutics with Buy and $50 price target, among five Monday analyst initiations spanning biotech, fintech, and enterprise software. Analyst wave beyond mega-cap AI signals capital rotation toward biotech and fintech; tech leaders should monitor sector valuations and deal patterns for M&A and stack alignment.
Top Wall Street analysts changed their outlook on these top names.
For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Goldman Sachs analyst Eric Sheridan initiated coverage on Neutron Holdings Inc (NASDAQ:LIME) with a Buy rating and announced a price target of $39.
Neutron Holdings shares closed at $28.23 on Friday.
See how other analysts view this stock.
Top Wall Street analysts changed outlook on top names. Analyst rating changes include upgrades, downgrades, and initiations. See…
Top Wall Street analysts change outlook on top names. See analyst ratings page for changes, including…
Top Wall Street analysts changed their outlook on various stocks. Check out the analyst ratings page for upgrades, downgrades,…
Wall Street analysts changed outlook on top names. Check analyst ratings page for upgrades, downgrades, and initiations. See…
Top Wall Street analysts changed outlook on top names. See analyst ratings page for upgrades, downgrades, and initiations. Check…
Top Wall Street analysts changed outlook on top names. See analyst ratings page for all changes. Analysts have mixed views on…
